New £800-a-dose jab offers hope for diabetics suffering macular oedema

Brolucizumab treats fluid build-up in the eyes - called diabetic macular oedema - that can lead to blurred vision and, eventually, loss of sight.

Related Keywords

United Kingdom ,Nottingham ,Camberley ,Surrey ,Britons ,Bernadette Warren ,Winfried Amoaku ,Nottingham University Hospitals , ,Dailymail ,Health ,Nhs ,